Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
Feldman SR, Garton R, Averett W, Balkrishnan R, Vallee J. Feldman SR, et al. Expert Opin Pharmacother. 2003 Sep;4(9):1525-33. doi: 10.1517/14656566.4.9.1525. Expert Opin Pharmacother. 2003. PMID: 12943482 Review.
New biological agents add to the treatment options for psoriasis; however, they raise the already considerable cost of managing the disease. ...Developing rational, effective and acceptable strategies to manage psoriasis …
New biological agents add to the treatment options for psoriasis; however, they raise the already considerable cost …
Anti-TNF agents for the treatment of psoriasis.
Kircik LH, Del Rosso JQ. Kircik LH, et al. J Drugs Dermatol. 2009 Jun;8(6):546-59. J Drugs Dermatol. 2009. PMID: 19537380 Review.
DISCUSSION: Patients with mild disease may obtain symptomatic relief with topical agents and targeted phototherapy. Patients with moderate-to-severe disease are likely to benefit from systemic therapy. ...Safety data also continue to be collecte …
DISCUSSION: Patients with mild disease may obtain symptomatic relief with topical agents and targeted phototherapy. Patients with mod …
Initiative for quality in psoriasis and psoriatic arthritis.
Boehncke WH, Adebajo A, Cauli A, Nash P, Salvarani C, Kavanaugh AF. Boehncke WH, et al. J Rheumatol. 2008 Jul;35(7):1431-3. J Rheumatol. 2008. PMID: 18609739
The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are often followed, and considerable resources are needed for these chronic inflammatory diseases. ...These are the goals of the Quality Mov …
The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are oft …
Feedback